Literature DB >> 394839

Interferon: an anti-cancer agent?

T J Priestman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 394839     DOI: 10.1016/s0305-7372(79)80039-0

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  6 in total

Review 1.  Cautious optimism-the current role of immunotherapy in gastrointestinal cancers.

Authors:  S Mendis; S Gill
Journal:  Curr Oncol       Date:  2020-04-01       Impact factor: 3.677

2.  Interferon production by a human lymphoblastoid cell line (DG-75) free of the Epstein-Barr genome.

Authors:  A Lazar; S Reuveny; M Minai; A Traub; A Mizrahi
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

3.  Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study.

Authors:  K Winkler; G Beron; R Kotz; M Salzer-Kuntschik; J Beck; W Beck; W Brandeis; W Ebell; R Erttmann; U Göbel; W Havers; G Henze; L Hinderfield; P Höcker; A Jobke; H Jürgens; H Kabisch; G Landbeck; P Preusser; G Prindull; W Ramach; J Ritter; J Sekera; J Treuner; G Wüst
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

Review 4.  Drug-induced hair loss and hair growth. Incidence, management and avoidance.

Authors:  A Tosi; C Misciali; B M Piraccini; A M Peluso; F Bardazzi
Journal:  Drug Saf       Date:  1994-04       Impact factor: 5.606

5.  The treatment of cancer patients with human lymphoblastoid interferon. A comparison of two routes of administration.

Authors:  J A Knost; S A Sherwin; P G Abrams; J J Ochs; K A Foon; R Williams; R Tuttle; R K Oldham
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  The failure of human leukocyte interferon to influence the growth of human glioma cell populations: in vitro and in vivo studies.

Authors:  N J Bradley; J L Darling; N Oktar; H J Bloom; D G Thomas; A J Davies
Journal:  Br J Cancer       Date:  1983-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.